Report : North America Preoperative Infection Prevention & Wound Cleansing Device Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Preoperative Infection Prevention Devices and Preoperative Wound Cleansing Devices), Surgery (Cataract Surgery, Cesarean Surgery, Gastric Bypass, Appendectomy, Colectomy and Colostomy, Esophagectomy, Biopsy, Cholecystectomy, Mastectomy, Cosmetic Surgery, and Others), and Application (Preoperative Hair Removal, Preoperative Skin Preparation, Intraoperative Wound Irrigation Solution, and Others)
At 6.7% CAGR, the North America Preoperative Infection Prevention & Wound Cleansing Device Market is speculated to be worth US$ 1,256.00 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the North America preoperative infection prevention & wound cleansing device market was valued at US$ 798.48 million in 2021 and is expected to reach US$ 1,256.00 million by 2028, registering a CAGR of 6.7% from 2021 to 2028. Rising incidence of surgical site infections (SSIs) and increasing incidence of hospital acquired infections are the critical factors attributed to the North America preoperative infection prevention & wound cleansing device market expansion.
Surgical Site Infection (SSI) is the most common nosocomial infection and a common side effect of gastrointestinal surgery. Gastrointestinal surgical procedures and wound closure methods influence the occurrence of superficial wound infections. There has been a faster increase in simple incisional SSI infection cases than in deep incisional SSI and organ or space SSI. SSIs are treated with antibiotics; however, sometimes, additional procedures are needed to treat the infection. The rising geriatric population with compromised immunity and the increasing surgical procedures across the world fuel incidences of SSIs which drives the growth of the North America preoperative infection prevention & wound cleansing device market. SSIs place a significant clinical and economic burden on patients and the healthcare system, primarily due to increased morbidity, mortality, and hospital expenses. Prevention of SSIs requires surveillance activities leading to effective mitigation strategies. According to the CDC guidelines, SSI is classified into superficial incisional SSI, internal deep incisional SSI, and organ SSI. Factors such as contamination level and surgical techniques have been identified as strong predictors of SSI occurrence. According to the Agency of Healthcare Research and Quality, SSIs occur in ~2 to 4% of all the patients that undergo inpatient surgical procedures. SSIs are the leading cause of readmission to the hospital after surgery, and about 3% of the patients that acquire SSIs die. Owing to the rising number of SSIs cases, the need for preoperative infection prevention is growing as to prevent SSIs hospitals and healthcare centers are opting for preoperative infection prevention procedures.
On the contrary, high costs and reimbursement of advanced devices hurdles the growth of North America preoperative infection prevention & wound cleansing device market.
Based on product, the North America preoperative infection prevention & wound cleansing device market is bifurcated into preoperative infection prevention devices and preoperative wound cleansing devices. The preoperative infection prevention devices segment held 72.7% share of North America preoperative infection prevention & wound cleansing device market in 2021, amassing US$ 580.77 million. It is projected to garner US$ 916.18 million by 2028 to expand at 6.7% CAGR during 2021–2028. The preoperative infection prevention devices segment is further subsegmented into infection prevention supplies, medical waste disposable devices, and infection prevention equipments.
Based on surgery, the North America preoperative infection prevention & wound cleansing device market is segmented into cataract surgery, cesarean surgery, gastric bypass, appendectomy, colectomy and colostomy, esophagectomy, biopsy, cholecystectomy, mastectomy, cosmetic surgery, and others. The cosmetic surgery segment held 22.3% share of North America preoperative infection prevention & wound cleansing device market in 2021, amassing US$ 178.27 million. It is projected to garner US$ 286.70 million by 2028 to expand at 7.0% CAGR during 2021–2028.
Based on application, the North America preoperative infection prevention & wound cleansing device market is segmented into preoperative hair removal, preoperative skin preparation, intraoperative wound irrigation solution, and others. The preoperative hair removal segment held 42.7% share of North America preoperative infection prevention & wound cleansing device market in 2021, amassing US$ 340.88 million. It is projected to garner US$ 535.33 million by 2028 to expand at 6.7% CAGR during 2021–2028. The preoperative hair removal segment is further subsegmented into clippers, razors, and depilators. The preoperative skin preparation segment is further subsegmented into single use and multiple use. The intraoperative wound irrigation solution segment is further subsegmented into detergents, antibiotic laden lavage, antiseptic agents, and sterile normal saline market.
Based on country, the North America preoperative infection prevention & wound cleansing device market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 80.8% share of North America preoperative infection prevention & wound cleansing device market in 2021. It was assessed at US$ 645.02 million in 2021 and is likely to hit US$ 1,014.21 million by 2028, exhibiting a CAGR of 6.7% during the forecast period.
Key players profiles in the North America preoperative infection prevention & wound cleansing device market report are 3M Co; Bactiguard AB; Becton Dickinson and Co; bioMerieux SA; Cardinal Health Inc; Dynarex Corp; Getinge AB; Medline Industries Inc; and Steris Plc, among others.
Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: sam@businessmarketinsights.com